CL 216942

Known as: CL-216942, CL216,942 
 

Topic mentions per year

Topic mentions per year

1981-1986
01219811986

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
Twenty-three evaluable patients with refractory epithelial ovarian cancer were treated with bisantrene (CL216,942). The drug was… (More)
Is this relevant?
1983
1983
A phase II study of ADAH was conducted in thirty patients with biopsy-prove metastatic or recurrent colorectal carcinoma in order… (More)
Is this relevant?
1982
1982
9,10-Anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride (CL 216942; bisantrene hydrochloride… (More)
Is this relevant?
1981
1981
9,10-Anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942) is a new anthracene… (More)
Is this relevant?
1981
1981
We have utilized a recently developed human tumor cloning system to screen for antitumor effects in vitro of a new anthracene… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?